0000000000370569

AUTHOR

E. Crevisy

showing 5 related works from this author

Personality types in individuals with type 1 and type 2 diabetes

2020

Objective The Type A personality, characterized by impatience, strong career ambition and competitiveness, is associated with greater sensitivity to external stress. Type 1 diabetes (T1D) is an auto-immune disease, which is potentially influenced by stress, unlike type 2 diabetes (T2D). The aim of this study was to assess whether individuals with T1D and T2D exhibited significant differences on the Type A personality scale. We also assessed personality in patients with thyroid auto-immune diseases to validate potential links between auto-immune disease and Type A personality. Design and methods The Bortner questionnaire was used to assess Type A personality in 188 patients with T1D, 430 pa…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismDiseaseType 2 diabeteslcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicinePersonalitythyroid disease030212 general & internal medicinetype a personalityauto-immunitymedia_commonType 1 diabeteslcsh:RC648-665business.industryResearchThyroid diseaseThyroidnutritional and metabolic diseasesType A and Type B personality theorymedicine.diseasemedicine.anatomical_structurediabetes mellitusbusinessEndocrine Connections
researchProduct

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis

2015

Aim Non-alcoholic fatty liver disease (NAFLD) is commonly associated with Type 2 diabetes. Recently, it has been suggested that NAFLD is also frequently associated with Type 1 diabetes and diabetic complications. In this study, we set out to determine whether Type 1 diabetes was associated with liver fat content measured using magnetic resonance imaging. Methods One hundred and twenty-eight patients with Type 1 diabetes, 264 patients with Type 2 diabetes and 67 participants without diabetes were included in this study. Hepatic steatosis was defined as a liver fat content > 5.5%. Results People with Type 1 diabetes and controls were similar for age and BMI. Liver fat content was significantl…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGastroenterologyBody Mass IndexEndocrinologyNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineDiabetes mellitusPrevalenceInternal MedicineHumansMass ScreeningMedicineObesityProspective StudiesProspective cohort studyMass screeningAgedType 1 diabetesbusiness.industryFatty liverAge FactorsMiddle AgedOverweightmedicine.diseaseMagnetic Resonance ImagingDiabetes Mellitus Type 1Diabetes Mellitus Type 2LiverIntima-media thicknessFemaleFranceSteatosisbusinessBody mass indexDiabetic Medicine
researchProduct

Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene

2020

Abstract Aim The aim of the present study was to identify the affected gene in a French family with maturity-onset diabetes of the young (MODY) using whole-exome sequencing (WES). Methods WES was performed in one patient with MODY, and candidate variants were confirmed in members of the immediate family by Sanger sequencing. Results In the proband, a new heterozygous missense mutation (c.340A>C) was identified in the NEUROD1 gene by WES analysis and confirmed by Sanger sequencing. Additional Sanger sequencing of the proband's sister and mother revealed the same heterozygous mutation. The proband and his sister displayed typical clinical characteristics of MODY, while their mother had the sa…

AdultMaleProbandHeterozygoteEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Mutation MissenseMothers030209 endocrinology & metabolism030204 cardiovascular system & hematologyBiology03 medical and health sciencessymbols.namesake0302 clinical medicineEndocrinologyDiabetic NeuropathiesExome SequencingBasic Helix-Loop-Helix Transcription FactorsInternal MedicinemedicineHumansHypoglycemic AgentsInsulinMissense mutationDiabetic NephropathiesAge of OnsetGeneExome sequencingAgedSanger sequencingGeneticsDiabetic RetinopathySiblingsGeneral Medicinemedicine.disease[SDV] Life Sciences [q-bio]Diabetes Mellitus Type 2Mutation (genetic algorithm)symbolsFemaleFranceMODY 6NEUROD1 Gene
researchProduct

Liraglutide reduces postprandial hyperlipidaemia by increasing apoB48 catabolism and by reducing apoB48 production

2016

IF 6.080; International audience

[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismliraglutideapoB48Diabetic dyslipidemiaPostprandial hyperlipidemiaGLP1 agonist[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
researchProduct

Feasibility and Preliminary Results of an Ambutatory Educational Program for the Use of Fsl in 359 Insulin-Treated Patients

2018

[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
researchProduct